Increased Osteoclast Activity in the Presence of Increased Homocysteine Concentrations
Open Access
- 1 December 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (12), 2348-2353
- https://doi.org/10.1373/clinchem.2005.053363
Abstract
Background: Increased plasma homocysteine (HCY) may be an independent risk factor for osteoporotic fractures and therefore may also adversely affect bone metabolism. We analyzed the effect of HCY on human osteoclast (OC) activity.Keywords
This publication has 42 references indexed in Scilit:
- Osteoporosis Prevalence and Levels of Treatment in Primary Care: The Australian BoneCare StudyJournal of Bone and Mineral Research, 2004
- American Association of Clinical Endocrinologists Medical Guidelines For Clinical Practice For The Prevention and Treatment of Postmenopausal Osteoporosis: 2001 Edition, With Selected Updates For 2003Endocrine Practice, 2003
- Adverse Outcomes of Osteoporotic Fractures in the General PopulationJournal of Bone and Mineral Research, 2003
- Economic Evaluation of Interventions for OsteoporosisOsteoporosis International, 2002
- Recent developments in the epidemiology of osteoporosisCurrent Opinion in Rheumatology, 2002
- A New Approach to the Development of Assessment Guidelines for OsteoporosisOsteoporosis International, 2002
- Mortality after all major types of osteoporotic fracture in men and women: an observational studyThe Lancet, 1999
- Loss of bone mineral density in women athletes during aging.Calcified Tissue International, 1998
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Costs and health effects of osteoporotic fracturesBone, 1994